At Holdings Channel, we have reviewed the latest batch of the 27 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Merck & Co Inc (Symbol: MRK) was held by 15 of these ...

“That number will continue ... “That’s built on a lot of investment, primarily in workforce, as well as a fairly positive business climate here.” On Tuesday, Merck said it expects to ...

I bet the numbers will be good, but there are other issues. I also want to get more of a readout on the drugs that Merck picked up in its recent wave of acquisitions, one for pulmonary arterial ...

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno ...